Pharmacotherapy for Pulmonary Hypertension

Robin H Steinhorn

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Pulmonary arterial hypertension is a serious disease with significant morbidity and mortality. Although it can occur idiopathically, it is more commonly associated with other cardiac or lung diseases. While most of the available therapies have been tested in adult populations and most therapies in children remain off-label, new reports and randomized trials are emerging that inform the treatment of pediatric populations. This review discusses currently available therapies for pediatric pulmonary hypertension, their biological rationales, and evidence for their clinical effectiveness.

Original languageEnglish (US)
Pages (from-to)1130-1146
Number of pages17
JournalPediatric Clinics of North America
Issue number5
StatePublished - Oct 2012
Externally publishedYes


  • Endothelin
  • Nitric oxide
  • Phosphodiesterase
  • Prostacyclin
  • Pulmonary hypertension
  • Pulmonary vasculature
  • Vasodilator

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Pharmacotherapy for Pulmonary Hypertension'. Together they form a unique fingerprint.

Cite this